Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers

Cancer Biology and Therapy

Volumn 16, Issue 10, 2015, Pages 1557-1565

  Haun, Randy S ^a,b   Quick, Charles M ^c   Siegel, Eric R ^c   Raju, Ilangovan ^b   Mackintosh, Samuel G ^c   Tackett, Alan J ^c  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

biomarkers; bioorthogonal labeling; cell surface proteins; click chemistry; glycoproteins; pancreatic cancer; proteomic profiling

Indexed keywords

BIOTIN; CELL SURFACE PROTEIN; GLYCOPROTEIN; STREPTAVIDIN; TUMOR MARKER; MEMBRANE PROTEIN;

ARTICLE; CANCER TISSUE; CLICK CHEMISTRY; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PANCREATIC TISSUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; IMMUNOLOGY; METABOLISM; PANCREAS TUMOR; PATHOLOGY;

BIOMARKERS, TUMOR; HUMANS; MEMBRANE PROTEINS; PANCREATIC NEOPLASMS;

EID: 84945476729     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1071740     Document Type: Article

References (64)

1. R.Siegel, J.Ma, Z.Zou, A.Jemal. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29; PMID:24399786; http://dx.doi.org/10.3322/caac.21208
2. L.Rahib, B.D.Smith, R.Aizenberg, A.B.Rosenzweig, J.M.Fleshman, L.M.Matrisian. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74:2913-21; PMID:24840647; http://dx.doi.org/10.1158/0008-5472.CAN-14-0155
3. T.Conroy, F.Desseigne, M.Ychou, O.Bouche, R.Guimbaud, Y.Becouarn, A.Adenis, J.L.Raoul, S.Gourgou-Bourgade, C.de la Fouchardière, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364:1817-25; PMID:21561347; http://dx.doi.org/10.1056/NEJMoa1011923
4. D.D.Von Hoff, T.Ervin, F.P.Arena, E.G.Chiorean, J.Infante, M.Moore, T.Seay, S.A.Tjulandin, W.W.Ma, M.N.Saleh, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369:1691-703; PMID:24131140; http://dx.doi.org/10.1056/NEJMoa1304369
5. D.E.Gerber. Targeted therapies: a new generation of cancer treatments. Am Fam Physician 2008; 77:311-9; PMID:18297955
6. B.Wollscheid, D.Bausch-Fluck, C.Henderson, R.O'Brien, M.Bibel, R.Schiess, R.Aebersold, J.D.Watts. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol 2009; 27:378-86; PMID:19349973; http://dx.doi.org/10.1038/nbt.1532
7. N.J.Agard, C.R.Bertozzi. Chemical approaches to perturb, profile, and perceive glycans. Acc Chem Res 2009; 42:788-97; PMID:19361192; http://dx.doi.org/10.1021/ar800267j
8. D.J.Vocadlo, H.C.Hang, E.J.Kim, J.A.Hanover, C.R.Bertozzi. A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proc Natl Acad Sci U S A 2003; 100:9116-21; PMID:12874386; http://dx.doi.org/10.1073/pnas.1632821100
9. S.C.Hubbard, M.Boyce, C.T.McVaugh, D.M.Peehl, C.R.Bertozzi. Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells. Bioorg Med Chem Lett 2011; 21:4945-50; PMID:21798741; http://dx.doi.org/10.1016/j.bmcl.2011.05.045
10. L.Yang, J.O.Nyalwidhe, S.Guo, R.R.Drake, O.J.Semmes. Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol Cell Proteomics 2011; 10:M110 007294
11. A.Holmberg, A.Blomstergren, O.Nord, M.Lukacs, J.Lundeberg, M.Uhlen. The biotin-streptavidin interaction can be reversibly broken using water at elevated temperatures. Electrophoresis 2005; 26:501-10; PMID:15690449; http://dx.doi.org/10.1002/elps.200410070
12. B.Zhang. CD73: a novel target for cancer immunotherapy. Cancer Res 2010; 70:6407-11; PMID:20682793; http://dx.doi.org/10.1158/0008-5472.CAN-10-1544
13. S.K.Johnson, R.A.Dennis, G.W.Barone, L.W.Lamps, R.S.Haun. Differential Expression of Insulin Growth Factor Binding Protein 5 in Pancreatic Adenocarcinomas: Identification Using DNA Microarray. Mol Carcinog 2006; 45:814-27; PMID:16865675; http://dx.doi.org/10.1002/mc.20203
14. C.A.Iacobuzio-Donahue, A.Maitra, G.L.Shen-Ong, T.van Heek, R.Ashfaq, R.Meyer, K.Walter, K.Berg, M.A.Hollingsworth, J.L.Cameron, et al. Discovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology. Am J Pathol 2002; 160:1239-49; PMID:11943709; http://dx.doi.org/10.1016/S0002-9440(10)62551-5
15. C.A.Iacobuzio-Donahue, B.Ryu, R.H.Hruban, S.E.Kern. Exploring the Host Desmoplastic Response to Pancreatic Carcinoma: Gene Expression of Stromal and Neoplastic Cells at the Site of Primary Invasion. Am J Pathol 2002; 160:91-9; PMID:11786403; http://dx.doi.org/10.1016/S0002-9440(10)64353-2
16. H.Han, D.J.Bearss, L.W.Browne, R.Calaluce, R.B.Nagle, D.D.Von Hoff. Identification of Differentially Expressed Genes in Pancreatic Cancer Cells Using cDNA Microarray. Cancer Res 2002; 62:2890-6; PMID:12019169
17. C.D.Logsdon, D.M.Simeone, C.Binkley, T.Arumugam, J.K.Greenson, T.J.Giordano, D.E.Misek, R.Kuick, S.Hanash. Molecular Profiling of Pancreatic Adenocarcinoma and Chronic Pancreatitis Identifies Multiple Genes Differentially Regulated in Pancreatic Cancer. Cancer Res 2003; 63:2649-57; PMID:12750293
18. C.A.Iacobuzio-Donahue, R.Ashfaq, A.Maitra, N.V.Adsay, G.L.Shen-Ong, K.Berg, M.A.Hollingsworth, J.L.Cameron, C.J.Yeo, S.E.Kern, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003; 63:8614-22; PMID:14695172
19. T.Crnogorac-Jurcevic, E.Efthimiou, T.Nielsen, J.Loader, B.Terris, G.Stamp, A.Baron, A.Scarpa, N.R.Lemoine. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 2002; 21:4587-94; PMID:12085237; http://dx.doi.org/10.1038/sj.onc.1205570
20. T.Crnogorac-Jurcevic, E.Missiaglia, E.Blaveri, R.Gangeswaran, M.Jones, B.Terris, E.Costello, J.P.Neoptolemos, N.R.Lemoine. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003; 201:63-74; PMID:12950018; http://dx.doi.org/10.1002/path.1418
21. E.Missiaglia, E.Blaveri, B.Terris, Y.H.Wang, E.Costello, J.P.Neoptolemos, T.Crnogorac-Jurcevic, N.R.Lemoine. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 2004; 112:100-12; PMID:15305381; http://dx.doi.org/10.1002/ijc.20376
22. C.A.Iacobuzio-Donahue, A.Maitra, M.Olsen, A.W.Lowe, N.T.van Heek, C.Rosty, K.Walter, N.Sato, A.Parker, R.Ashfaq, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003; 162:1151-62; PMID:12651607; http://dx.doi.org/10.1016/S0002-9440(10)63911-9
23. Z.J.Tan, X.G.Hu, G.S.Cao, Y.Tang. Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray. World J Gastroenterol 2003; 9:818-23; PMID:12679940
24. T.Nakamura, Y.Furukawa, H.Nakagawa, T.Tsunoda, H.Ohigashi, K.Murata, O.Ishikawa, K.Ohgaki, N.Kashimura, M.Miyamoto, et al. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004; 23:2385-400; PMID:14767473; http://dx.doi.org/10.1038/sj.onc.1207392
25. R.Grutzmann, C.Pilarsky, O.Ammerpohl, J.Luttges, A.Bohme, B.Sipos, M.Foerder, I.Alldinger, B.Jahnke, H.K.Schackert, et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 2004; 6:611-22; PMID:15548371; http://dx.doi.org/10.1593/neo.04295
26. N.B.Prasad, A.V.Biankin, N.Fukushima, A.Maitra, S.Dhara, A.G.Elkahloun, R.H.Hruban, M.Goggins, S.D.Leach. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005; 65:1619-26; PMID:15753353; http://dx.doi.org/10.1158/0008-5472.CAN-04-1413
27. H.Friess, J.Ding, J.Kleeff, L.Fenkell, J.A.Rosinski, A.Guweidhi, J.F.Reidhaar-Olson, M.Korc, J.Hammer, M.W.Büchler. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci 2003; 60:1180-99; PMID:12861384
28. R.Grutzmann, H.D.Saeger, J.Luttges, H.K.Schackert, H.Kalthoff, G.Kloppel, C.Pilarsky. Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives. Int J Colorectal Dis 2004; 19:401-13; PMID:14745573; http://dx.doi.org/10.1007/s00384-003-0563-3
29. R.Brandt, R.Grutzmann, A.Bauer, R.Jesnowski, J.Ringel, M.Lohr, C.Pilarsky, J.D.Hoheisel. DNA microarray analysis of pancreatic malignancies. Pancreatology 2004; 4:587-97; PMID:15557762; http://dx.doi.org/10.1159/000082241
30. J.Gardner-Thorpe, H.Ito, S.W.Ashley, E.E.Whang. Differential display of expressed genes in pancreatic cancer cells. Biochem Biophys Res Commun 2002; 293:391-5; PMID:12054612; http://dx.doi.org/10.1016/S0006-291X(02)00237-1
31. S.P.Gygi, Y.Rochon, B.R.Franza, R.Aebersold. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19:1720-30; PMID:10022859
32. R.Chen, S.Pan, T.A.Brentnall, R.Aebersold. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 2005; 4:523-33; PMID:15684406; http://dx.doi.org/10.1074/mcp.R500004-MCP200
33. M.Gronborg, T.Z.Kristiansen, A.Iwahori, R.Chang, R.Reddy, N.Sato, H.Molina, O.N.Jensen, R.H.Hruban, M.G.Goggins, et al. Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach. Mol Cell Proteomics 2006; 5:157-71; PMID:16215274; http://dx.doi.org/10.1074/mcp.M500178-MCP200
34. W.Zhang, M.Erkan, I.Abiatari, N.A.Giese, K.Felix, H.Kayed, M.W.Büchler, H.Friess, J.Kleeff. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in pancreatic neoplasm and pancreatic stellate cells. Cancer Biol Ther 2007; 6:218-27; PMID:17224648; http://dx.doi.org/10.4161/cbt.6.2.3623
35. M.Li, Q.Zhai, U.Bharadwaj, H.Wang, F.Li, W.E.Fisher, C.Chen, Q.Yao. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 2006; 106:2284-94; PMID:16604531; http://dx.doi.org/10.1002/cncr.21862
36. W.Schneiderhan, F.Diaz, M.Fundel, S.Zhou, M.Siech, C.Hasel, P.Möller, J.E.Gschwend, T.Seufferlein, T.Gress, et al. Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay. J Cell Sci 2007; 120:512-9; PMID:17227797; http://dx.doi.org/10.1242/jcs.03347
37. H.Immervoll, D.Hoem, O.J.Steffensen, H.Miletic, A.Molven. Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers. J Histochem Cytochem 2011; 59:441-55; PMID:21411814; http://dx.doi.org/10.1369/0022155411398275
38. M.Takada, M.Yamamoto, Y.Saitoh. The significance of CD44 in human pancreatic cancer: I. High expression of CD44 in human pancreatic adenocarcinoma. Pancreas 1994; 9:748-52; PMID:7531334; http://dx.doi.org/10.1097/00006676-199411000-00013
39. F.Gansauge, S.Gansauge, A.Zobywalski, C.Scharnweber, K.H.Link, A.K.Nussler, H.G.Beger. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Cancer Res 1995; 55:5499-503; PMID:7585621
40. M.Korc, B.Chandrasekar, Y.Yamanaka, H.Friess, M.Buchier, H.G.Beger. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α. J Clin Invest 1992; 90:1352-60; PMID:1401070; http://dx.doi.org/10.1172/JCI116001
41. L.Zhang, S.Z.Yuan. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma. Hepatobiliary Pancreat Dis Int 2002; 1:620-3; PMID:14607699
42. K.Tobita, H.Kijima, S.Dowaki, H.Kashiwagi, Y.Ohtani, Y.Oida, H.Yamazaki, M.Nakamura, Y.Ueyama, M.Tanaka, et al. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis. Int J Mol Med 2003; 11:305-9; PMID:12579331
43. D.Cao, S.R.Hustinx, G.Sui, P.Bala, N.Sato, S.Martin, A.Maitra, K.M.Murphy, J.L.Cameron, C.J.Yeo, et al. Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags. Cancer Biol Ther 2004; 3:1081-9; discussion 90-1; PMID:15467436; http://dx.doi.org/10.4161/cbt.3.11.1175
44. A.Van den Broeck, H.Vankelecom, R.Van Eijsden, O.Govaere, B.Topal. Molecular markers associated with outcome and metastasis in human pancreatic cancer. J Exp Clin Cancer Res 2012; 31:68; PMID:22925330; http://dx.doi.org/10.1186/1756-9966-31-68
45. R.Chen, T.A.Brentnall, S.Pan, K.Cooke, K.W.Moyes, Z.Lane, D.A.Crispin, D.R.Goodlett, R.Aebersold, M.P.Bronner. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics 2007; 6:1331-42; PMID:17496331; http://dx.doi.org/10.1074/mcp.M700072-MCP200
46. H.Kim, G.Zhai, Z.Liu, S.Samuel, N.Shah, E.E.Helman, J.A.Knowles, C.R.Stockard, N.S.Fineberg, W.E.Grizzle, et al. Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anticancer Drugs 2011; 22:864-74; PMID:21730821; http://dx.doi.org/10.1097/CAD.0b013e328349311e
47. B.A.Faller, B.Burtness. Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy. Biologics 2009; 3:419-28; PMID:19774209
48. O.Canbolat, I.Durak, R.Cetin, M.Kavutcu, S.Demirci, S.Ozturk. Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Res Treat 1996; 37:189-93; PMID:8750586; http://dx.doi.org/10.1007/BF01806500
49. A.Supernat, A.Markiewicz, M.Welnicka-Jaskiewicz, B.Seroczynska, J.Skokowski, A.Sejda, J.Szade, P.Czapiewski, W.Biernat, A.Zaczek. CD73 expression as a potential marker of good prognosis in breast carcinoma. Appl Immunohistochem Mol Morphol 2012; 20:103-7; PMID:22553809; http://dx.doi.org/10.1097/PAI.0b013e3182311d82
50. H.K.Oh, J.I.Sin, J.Choi, S.H.Park, T.S.Lee, Y.S.Choi. Overexpression of CD73 in epithelial ovarian carcinoma is associated with better prognosis, lower stage, better differentiation and lower regulatory T cell infiltration. J Gynecol Oncol 2012; 23:274-81; PMID:23094131; http://dx.doi.org/10.3802/jgo.2012.23.4.274
51. E.Aliagas, A.Vidal, L.Texido, J.Ponce, E.Condom, M.Martin-Satue. High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors. Mediators Inflamm 2014; 2014:509027; PMID:24707115; http://dx.doi.org/10.1155/2014/509027
52. K.Flocke, G.Lesch, H.P.Elsasser, K.Bosslet, H.G.Mannherz. Monoclonal antibodies against 5′-nucleotidase from a human pancreatic tumor cell line: their characterization and inhibitory capacity on tumor cell adhesion to fibronectin substratum. Eur J Cell Biol 1992; 58:62-70; PMID:1644065
53. K.Flocke, H.G.Mannherz. Isolation and characterization of 5′-nucleotidase of a human pancreatic tumor cell line. Biochim Biophys Acta 1991; 1076:273-81; PMID:1998727; http://dx.doi.org/10.1016/0167-4838(91)90278-8
54. D.Jin, J.Fan, L.Wang, L.F.Thompson, A.Liu, B.J.Daniel, T.Shin, T.J.Curiel, B.Zhang. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res 2010; 70:2245-55; PMID:20179192; http://dx.doi.org/10.1158/0008-5472.CAN-09-3109
55. Y.R.Hadari, R.Arbel-Goren, Y.Levy, A.Amsterdam, R.Alon, R.Zakut, Y.Zick. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 2000; 113 (Pt 13):2385-97; PMID:10852818
56. Y.Levy, R.Arbel-Goren, Y.R.Hadari, S.Eshhar, D.Ronen, E.Elhanany, B.Geiger, Y.Zick. Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem 2001; 276:31285-95; PMID:11371555; http://dx.doi.org/10.1074/jbc.M100340200
57. R.L.Gundry, K.Raginski, Y.Tarasova, I.Tchernyshyov, D.Bausch-Fluck, S.T.Elliott, K.R.Boheler, J.E.Van Eyk, B.Wollscheid. The mouse C2C12 myoblast cell surface N-linked glycoproteome: Identification, glycosite occupancy, and membrane orientation. Mol Cell Proteomics 2009; 8:2555-69; PMID:19656770; http://dx.doi.org/10.1074/mcp.M900195-MCP200
58. R.Schiess, L.N.Mueller, A.Schmidt, M.Mueller, B.Wollscheid, R.Aebersold. Analysis of cell surface proteome changes via label-free, quantitative mass spectrometry. Mol Cell Proteomics 2009; 8:624-38; PMID:19036722; http://dx.doi.org/10.1074/mcp.M800172-MCP200
59. R.S.Haun, C.Y.Fan, S.G.Mackintosh, H.Zhao, A.J.Tackett. CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture. J Proteomics Bioinform 2014; Suppl 10:S10003; PMID:25635161
60. S.Byrum, N.L.Avaritt, S.G.Mackintosh, J.M.Munkberg, B.D.Badgwell, W.L.Cheung, A.J.Tackett. A quantitative proteomic analysis of FFPE melanoma. J Cutan Pathol 2011; 38:933-6; PMID:21883366; http://dx.doi.org/10.1111/j.1600-0560.2011.01761.x
61. S.Byrum, S.G.Mackintosh, R.D.Edmondson, W.L.Cheung, S.D.Taverna, A.J.Tackett. Analysis of Histone Exchange during Chromatin Purification. J Integr OMICS 2011; 1:61-5; PMID:21709819
62. S.D.Byrum, S.D.Taverna, A.J.Tackett. Quantitative analysis of histone exchange for transcriptionally active chromatin. J Clin Bioinforma 2011; 1:17; PMID:21884633; http://dx.doi.org/10.1186/2043-9113-1-17
63. S.D.Byrum, S.K.Larson, N.L.Avaritt, L.E.Moreland, S.G.Mackintosh, W.L.Cheung, A.J.Tackett. Quantitative Proteomics Identifies Activation of Hallmark Pathways of Cancer in Patient Melanoma. J Proteomics Bioinform 2013; 6:43-50; PMID:23976835; http://dx.doi.org/10.4172/jpb.1000260
64. B.Zybailov, A.L.Mosley, M.E.Sardiu, M.K.Coleman, L.Florens, M.P.Washburn. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 2006; 5:2339-47; PMID:16944946; http://dx.doi.org/10.1021/pr060161n